BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 27363666)

  • 1. [Synergistic activity and clinical efficacy of fosfomycin and ciprofloxacin combination treatment for soft tissue infection caused by carbapenemase-producing Enterobacter cloacae].
    Gómez-Garcés JL; Gil-Romero Y; Vazquez O; Merino F
    Enferm Infecc Microbiol Clin; 2017 Feb; 35(2):135-136. PubMed ID: 27363666
    [No Abstract]   [Full Text] [Related]  

  • 2. Extended-spectrum beta-lactamase-producing and carbapenemase-producing Enterobacter cloacae ventriculitis successfully treated with intraventricular colistin.
    Cascio A; Mezzatesta ML; Odierna A; Di Bernardo F; Barberi G; Iaria C; Stefani S; Giordano S
    Int J Infect Dis; 2014 Mar; 20():66-7. PubMed ID: 24412601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive increase of resistance in Enterobacteriaceae urinary isolates from kidney transplant recipients over the past decade: narrowing of the therapeutic options.
    Origüen J; Fernández-Ruiz M; López-Medrano F; Ruiz-Merlo T; González E; Morales JM; Fiorante S; San-Juan R; Villa J; Orellana MÁ; Andrés A; Aguado JM
    Transpl Infect Dis; 2016 Aug; 18(4):575-84. PubMed ID: 27373698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colistin-resistant Enterobacteriaceae infections: clinical and molecular characterization and analysis of in vitro synergy.
    de Maio Carrillho CM; Gaudereto JJ; Martins RC; de Castro Lima VA; de Oliveira LM; Urbano MR; Perozin JS; Levin AS; Costa SF
    Diagn Microbiol Infect Dis; 2017 Mar; 87(3):253-257. PubMed ID: 27939820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of the next-generation aminoglycoside plazomicin alone and in combination with colistin, meropenem, fosfomycin or tigecycline against carbapenemase-producing Enterobacteriaceae strains.
    Rodríguez-Avial I; Pena I; Picazo JJ; Rodríguez-Avial C; Culebras E
    Int J Antimicrob Agents; 2015 Dec; 46(6):616-21. PubMed ID: 26391381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence of AcrAB-mediated tigecycline resistance in a clinical isolate of Enterobacter cloacae during ciprofloxacin treatment.
    Hornsey M; Ellington MJ; Doumith M; Scott G; Livermore DM; Woodford N
    Int J Antimicrob Agents; 2010 May; 35(5):478-81. PubMed ID: 20189357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute pancreatitis related to tigecycline: case report and review of the literature.
    Gilson M; Moachon L; Jeanne L; Dumaine V; Eyrolle L; Morand P; Ben m'Rad M; Salmon D
    Scand J Infect Dis; 2008; 40(8):681-3. PubMed ID: 18979610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Activity of Fosfomycin Against Extended-Spectrum Beta-Lactamase-Producing Isolates of Enterobacteriaceae Recovered from Urinary Tract Infections: A Single-Center Study Over a Period of 12 Years.
    Aris P; Boroumand MA; Rahbar M; Douraghi M
    Microb Drug Resist; 2018 Jun; 24(5):607-612. PubMed ID: 29064348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized comparative study of single-dose fosfomycin and 5-day ciprofloxacin in female patients with uncomplicated lower urinary tract infections.
    Ceran N; Mert D; Kocdogan FY; Erdem I; Adalati R; Ozyurek S; Goktas P
    J Infect Chemother; 2010 Dec; 16(6):424-30. PubMed ID: 20585969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Multiple brain abscesses complicating Enterobacter cloacae sepsis in a premature infant].
    Traoré P; Coquery S; Zupan-Simunek V; Guibert M; Boileau P
    Arch Pediatr; 2010 Sep; 17 Suppl 4():S184-7. PubMed ID: 20826330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection, treatment, and prevention of carbapenemase-producing Enterobacteriaceae: recommendations from an International Working Group.
    Levy Hara G; Gould I; Endimiani A; Pardo PR; Daikos G; Hsueh PR; Mehtar S; Petrikkos G; Casellas JM; Daciuk L; Paciel D; Novelli A; Saginur R; Pryluka D; Medina J; Savio E
    J Chemother; 2013 Jun; 25(3):129-40. PubMed ID: 23783137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The clinical manifestation and drug sensitive tests of lower respiratory tract infection by enterobacter cloacae. The Pulmonary Infection and Fibrosis Group, Thoracic Society Shanghai Medical Association].
    Zhonghua Jie He He Hu Xi Za Zhi; 1997 Aug; 20(4):208-11. PubMed ID: 10072803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outbreak of vim-1-carbapenemase-producing Enterobacter cloacae in a pediatric intensive care unit.
    Oteo J; Hernández-Almaraz JL; Gil-Antón J; Vindel A; Fernández S; Bautista V; Campos J
    Pediatr Infect Dis J; 2010 Dec; 29(12):1144-6. PubMed ID: 20686438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors and outcome of extended-spectrum β-lactamase-producing Enterobacter cloacae bloodstream infections.
    Qureshi ZA; Paterson DL; Pakstis DL; Adams-Haduch JM; Sandkovsky G; Sordillo E; Polsky B; Peleg AY; Bhussar MK; Doi Y
    Int J Antimicrob Agents; 2011 Jan; 37(1):26-32. PubMed ID: 21075605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Iatrogenic meningitis after diagnosis lumbar puncture: 3 cases reports in the paediatric Children's Hospital of Tunis].
    Smaoui H; Hariga D; Hajji N; Bouziri A; Ben Jaballah N; Barsaoui S; Bousnina S; Sammoud A; Kechrid A
    Bull Soc Pathol Exot; 2011 Feb; 104(1):10-3. PubMed ID: 21103965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of colistin sulfate against Enterobacteriaceae producing extended-spectrum β-lactamases.
    Ku YH; Lee MF; Chuang YC; Chen CC; Yu WL
    J Microbiol Immunol Infect; 2015 Dec; 48(6):699-702. PubMed ID: 24388585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colistin in combination with rifampin and imipenem for treating a blaVIM-1 metallo-beta-lactamase-producing Enterobacter cloacae disseminated infection in a liver transplant patient.
    Tascini C; Urbani L; Biancofiore G; Rossolini GM; Leonildi A; Gemignani G; Bindi ML; Mugnaioli C; Filipponi F; Menichetti F
    Minerva Anestesiol; 2008; 74(1-2):47-9. PubMed ID: 18059255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infective endocarditis due to Enterobacter cloacae resistant to third- and fourth-generation cephalosporins.
    Yoshino Y; Okugawa S; Kimura S; Makita E; Seo K; Koga I; Matsunaga N; Kitazawa T; Ota Y
    J Microbiol Immunol Infect; 2015 Apr; 48(2):226-8. PubMed ID: 23017689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pediatric case of New Delhi metallo-β-lactamase-1-producing Enterobacteriaceae in the United States.
    Green DA; Srinivas N; Watz N; Tenover FC; Amieva M; Banaei N
    Pediatr Infect Dis J; 2013 Nov; 32(11):1291-4. PubMed ID: 23743543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IMI-1-producing Enterobacter cloacae clinical isolate from Tahiti, French Polynesia.
    Cuzon G; Levy M; Jacob E; Dortet L; Naas T
    J Glob Antimicrob Resist; 2016 Jun; 5():1-2. PubMed ID: 27436456
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.